Archive for Articles

UPDATE! Recent IPOs added + FDA Calendar all up to date

Apr 28, 2014 No Comments by

BioPharmCatalyst is pleased to report that all catalysts in the FDA Calendar have been double checked following the latest reporting season that  finished a few weeks ago. There have been a few additions and alterations so please ensure you are up do date with the latest catalysts by visiting the FDA Calendar.   In addition, 27 […]

Articles Read more

Website update

Jul 13, 2013 No Comments by

Unfortunately, I have been laid up in bed over the last week but the good news is that I have just updated the Company Pipeline Database and FDA Calendar with the last week’s news. To find the latest week’s updates, go to the Company Pipeline Database and sort using by date in the “Updated” column […]

Articles Read more

BioPharmCatalyst 3rd Birthday – What lies ahead

Jun 28, 2013 2 Comments by

It’s official, BioPharmCatalyst celebrates its third anniversary today, while the FDA Calendar reaches four years old. Firstly, a big thank you to all the readers and followers of BioPharmCatalyst, whether you have been a user of the FDA Calendar since 2009, or if you have only just recently become a reader of the site. The […]

Articles Read more

Website update! – Company Pipeline and Financial Databases updated

Apr 29, 2013 No Comments

I have spent the last few weeks making significant updates to both the Company Pipeline Database and the Financial Database. COMPANY PIPELINE DATABASE This database now contains 1000 products from approximately 250 companies that have had or are currently trialling drugs in development (Phase 2 onwards). Over the past weeks updates have been made to […]

Read more

FDA Calendar – Glossary

Apr 21, 2013 2 Comments

A glossary of key terms used in the FDA Calendar is now available. This page is aimed at novice investors wanting to familiarise themselves with some of the key language used in the calendar. The glossary covers definitions regarding clinical trials, new PDUFA guidelines and other FDA related information. Readers can access the glossary under […]

Read more

Website update – apologies for the inconvenience

Oct 03, 2012 7 Comments

Apologies all for the inconvenience caused by my lack of updates. I have been overseas for the last two or so weeks with work and have no access to a latop, which makes it not possible to make updates to the calendars and other parts of the website when just I ‘m operating with an […]

Read more

Website update: I-app added + notice regarding daily news.

Aug 09, 2012 No Comments

Dear Readers, Some of you may have noticed recently a lack of daily news updates on the site. I can assure you that the FDA Calendar, Clinical Database and other databases have been updated and are currently running only about a day behind. However, I have been unable to post daily news updates due to […]

Read more

Pipeline profiles of recent Biotech Initial Public Offerings – DRTX TSRO HPTX MACK CCXI CEMP

Jul 28, 2012 No Comments

Hyperion Therapeutics, Inc (NASDAQ:HPTX) - Initial public offering July 2012.  PIPELINE Ravicti: PDUFA date October 23, 2012 for urea cycle disorders. Phase 2 trial completed for hepatic encephalopathy, or HE. End of Phase 2 meeting with the FDA planned for 4Q 2012. Durata Therapeutics Inc (NASDAQ:DRTX) - Initial public offering July 2012.  PIPELINE Dalbavancin: Phase 3 trial for the treatment of patients with acute bacterial skin and skin […]

Read more

New tool added – FDA Historical Calendar – A look back in history.

Jul 23, 2012 2 Comments

I am pleased to inform you that I have added another tool to the website. As users of the FDA Calendar may be aware, once a PDUFA catalyst has been completed the event is removed from the calendar. However, many readers have noted that they would prefer access to past FDA decisions. In light of […]

Read more

BioPharmCatalyst Celebrates Second Anniversary!

Jun 27, 2012 5 Comments

It’s official. celebrates its second birthday today and it’s time to thank those who made it all happen! The site has grown in readership significantly over the past two years and it is your positive feedback that gives me the energy to continue providing FREE unbiased tools to assist you in your investing and […]

Read more

Chatroom has been disabled

Jun 12, 2012 No Comments

I’ve decided to remove the chatroom from BioPharmCatalyst due to the high cost involved in maintaining the chatroom and a feeling that it doesn’t fit in with the philosophy of the website of giving unbiased tools for readers to use in their investing and trading decisions. I will continue to explore avenues to improve the website […]

Read more